These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 35883437)

  • 1. A Novel and Selective Dopamine Transporter Inhibitor,
    Kouhnavardi S; Ecevitoglu A; Dragačević V; Sanna F; Arias-Sandoval E; Kalaba P; Kirchhofer M; Lubec J; Niello M; Holy M; Zehl M; Pillwein M; Wackerlig J; Murau R; Mohrmann A; Beard KR; Sitte HH; Urban E; Sagheddu C; Pistis M; Plasenzotti R; Salamone JD; Langer T; Lubec G; Monje FJ
    Biomolecules; 2022 Jun; 12(7):. PubMed ID: 35883437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral and dopamine transporter binding properties of the modafinil analog (S, S)-CE-158: reversal of the motivational effects of tetrabenazine and enhancement of progressive ratio responding.
    Rotolo RA; Kalaba P; Dragacevic V; Presby RE; Neri J; Robertson E; Yang JH; Correa M; Bakulev V; Volkova NN; Pifl C; Lubec G; Salamone JD
    Psychopharmacology (Berl); 2020 Nov; 237(11):3459-3470. PubMed ID: 32770257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The novel atypical dopamine transport inhibitor CT-005404 has pro-motivational effects in neurochemical and inflammatory models of effort-based dysfunctions related to psychopathology.
    Rotolo RA; Presby RE; Tracy O; Asar S; Yang JH; Correa M; Murray F; Salamone JD
    Neuropharmacology; 2021 Feb; 183():108325. PubMed ID: 32956676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Novel Atypical Dopamine Uptake Inhibitor
    Rotolo RA; Dragacevic V; Kalaba P; Urban E; Zehl M; Roller A; Wackerlig J; Langer T; Pistis M; De Luca MA; Caria F; Schwartz R; Presby RE; Yang JH; Samels S; Correa M; Lubec G; Salamone JD
    Front Pharmacol; 2019; 10():682. PubMed ID: 31316379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential therapeutics for effort-related motivational dysfunction: assessing novel atypical dopamine transport inhibitors.
    Ecevitoglu A; Meka N; Rotolo RA; Edelstein GA; Srinath S; Beard KR; Carratala-Ros C; Presby RE; Cao J; Okorom A; Newman AH; Correa M; Salamone JD
    Neuropsychopharmacology; 2024 Jul; 49(8):1309-1317. PubMed ID: 38429498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effort-related motivational effects of the VMAT-2 inhibitor tetrabenazine: implications for animal models of the motivational symptoms of depression.
    Nunes EJ; Randall PA; Hart EE; Freeland C; Yohn SE; Baqi Y; Müller CE; López-Cruz L; Correa M; Salamone JD
    J Neurosci; 2013 Dec; 33(49):19120-30. PubMed ID: 24305809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. R-modafinil (armodafinil): a unique dopamine uptake inhibitor and potential medication for psychostimulant abuse.
    Loland CJ; Mereu M; Okunola OM; Cao J; Prisinzano TE; Mazier S; Kopajtic T; Shi L; Katz JL; Tanda G; Newman AH
    Biol Psychiatry; 2012 Sep; 72(5):405-13. PubMed ID: 22537794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dopamine reuptake inhibitor MRZ-9547 increases progressive ratio responding in rats.
    Sommer S; Danysz W; Russ H; Valastro B; Flik G; Hauber W
    Int J Neuropsychopharmacol; 2014 Dec; 17(12):2045-56. PubMed ID: 24964269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cocaine Self-Administration Produces Long-Lasting Alterations in Dopamine Transporter Responses to Cocaine.
    Siciliano CA; Fordahl SC; Jones SR
    J Neurosci; 2016 Jul; 36(30):7807-16. PubMed ID: 27466327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of uptake for dopamine, but not norepinephrine or 5-HT, increases selection of high effort instrumental activity: Implications for treatment of effort-related motivational symptoms in psychopathology.
    Yohn SE; Errante EE; Rosenbloom-Snow A; Somerville M; Rowland M; Tokarski K; Zafar N; Correa M; Salamone JD
    Neuropharmacology; 2016 Oct; 109():270-280. PubMed ID: 27329556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reinstatement of synaptic plasticity in the aging brain through specific dopamine transporter inhibition.
    Lubec J; Kalaba P; Hussein AM; Feyissa DD; Kotob MH; Mahmmoud RR; Wieder O; Garon A; Sagheddu C; Ilic M; Dragačević V; Cybulska-Klosowicz A; Zehl M; Wackerlig J; Sartori SB; Ebner K; Kouhnavardi S; Roller A; Gajic N; Pistis M; Singewald N; Leban JJ; Korz V; Malikovic J; Plasenzotti R; Sitte HH; Monje FJ; Langer T; Urban E; Pifl C; Lubec G
    Mol Psychiatry; 2021 Dec; 26(12):7076-7090. PubMed ID: 34244620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reward sensitivity deficits in a rat model of compulsive eating behavior.
    Moore CF; Leonard MZ; Micovic NM; Miczek KA; Sabino V; Cottone P
    Neuropsychopharmacology; 2020 Mar; 45(4):589-596. PubMed ID: 31622973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dopamine depleting agent tetrabenazine alters effort-related decision making as assessed by mouse touchscreen procedures.
    Yang JH; Presby RE; Rotolo RA; Quiles T; Okifo K; Zorda E; Fitch RH; Correa M; Salamone JD
    Psychopharmacology (Berl); 2020 Sep; 237(9):2845-2854. PubMed ID: 32561947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bupropion increases selection of high effort activity in rats tested on a progressive ratio/chow feeding choice procedure: implications for treatment of effort-related motivational symptoms.
    Randall PA; Lee CA; Podurgiel SJ; Hart E; Yohn SE; Jones M; Rowland M; López-Cruz L; Correa M; Salamone JD
    Int J Neuropsychopharmacol; 2014 Oct; 18(2):. PubMed ID: 25575584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of ( R)-Modafinil and Modafinil Analogues on Dopamine Dynamics Assessed by Voltammetry and Microdialysis in the Mouse Nucleus Accumbens Shell.
    Keighron JD; Quarterman JC; Cao J; DeMarco EM; Coggiano MA; Gleaves A; Slack RD; Zanettini C; Newman AH; Tanda G
    ACS Chem Neurosci; 2019 Apr; 10(4):2012-2021. PubMed ID: 30645944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of subchronic methamphetamine exposure on basal dopamine and stress-induced dopamine release in the nucleus accumbens shell of rats.
    Broom SL; Yamamoto BK
    Psychopharmacology (Berl); 2005 Sep; 181(3):467-76. PubMed ID: 15986185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil.
    Zolkowska D; Jain R; Rothman RB; Partilla JS; Roth BL; Setola V; Prisinzano TE; Baumann MH
    J Pharmacol Exp Ther; 2009 May; 329(2):738-46. PubMed ID: 19197004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The monoamine-oxidase B inhibitor deprenyl increases selection of high-effort activity in rats tested on a progressive ratio/chow feeding choice procedure: Implications for treating motivational dysfunctions.
    Yohn SE; Reynolds S; Tripodi G; Correa M; Salamone JD
    Behav Brain Res; 2018 Apr; 342():27-34. PubMed ID: 29292157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits.
    Salamone JD; Correa M; Farrar A; Mingote SM
    Psychopharmacology (Berl); 2007 Apr; 191(3):461-82. PubMed ID: 17225164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine D1 receptors in the medial orbitofrontal cortex support effort-related responding in rats.
    Münster A; Sommer S; Hauber W
    Eur Neuropsychopharmacol; 2020 Mar; 32():136-141. PubMed ID: 32029310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.